Diabetes care firm Embecta reached an agreement to buy Owen Mumford Holdings for up to 150 million pounds ($201 million) the companies said Thursday. The agreement includes an upfront payment of 100 ...

Embecta Corp. EMBC recently announced a definitive agreement to acquire Owen Mumford Holdings Limited, a pioneer in ...

The January ribbon cutting at embecta‘s new global headquarters in Parsippany was the latest step for one of the world’s largest pure-play diabetes management companies. “It was a really important ...

Embecta hits multi-year lows on GLP-1 fears, but offers 6%+ yield and deep value. Read the latest analysis on the stock and its announced acquisition of Owen Mumford here.

Becton, Dickinson and Co.’s board of directors approved the company’s diabetes spinoff, and set a date of April 1 for the move. The announcement of Embecta Corp.’s approval came Feb. 1, along with a ...

When Embecta spun out from BD just over a year ago, the newly formed diabetes giant already carried breakthrough designation for an insulin patch pump that would specifically target the Type 2 ...

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...

Embecta releases earnings for the most recent quarter on November 21. Wall Street analysts expect Embecta will report earnings per share of $0.398. Watch Embecta stock price in real-time on Markets ...

Under the transaction terms, BD shareholders received one share of Embecta stock for every five shares of BD that they held as of March 22. The Embecta spinoff severs all financial ties to BD, which ...

The company reported its results for the first quarter of fiscal 2023. It scored convincing beats on both the top and bottom lines. Before market open, Embecta published the figures for its first ...

Embecta said on May 12, 2023 that its board of directors declared a regular quarterly dividend of $0.15 per share ($0.60 annualized). Previously, the company paid $0.15 per share. Shares must be ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Diabetes care firm Embecta reached an agreement to buy ...